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Abstract 
Background: In engineered strains of Escherichia coli, bioconversion efficiency is determined by not only metabolic 
flux but also the turnover efficiency of relevant pathways. Methyl‑d‑erythritol 4‑phosphate (MEP)‑dependent carot‑
enoid biosynthesis in E. coli requires efficient turnover of precursors and balanced flux among precursors, cofactors, 
and cellular energy. However, the imbalanced supply of glyceraldehyde 3‑phosphate (G3P) and pyruvate precursors 
remains the major metabolic bottleneck. To address this problem, we manipulated various genetic targets related 
to the Entner–Doudoroff (ED)/pentose phosphate (PP) pathways. Systematic target modification was conducted to 
improve G3P and pyruvate use and rebalance the precursor and redox fluxes.
Results: Carotenoid production was improved to different degrees by modifying various targets in the Embden–
Meyerhof–Parnas (EMP) and ED pathways, which directed metabolic flux from the EMP pathway towards the ED path‑
way. The improvements in yield were much greater when the MEP pathway was enhanced. The coordinated modifi‑
cation of ED and MEP pathway targets using gene expression enhancement and protein coupling strategies in the pgi 
deletion background further improved carotenoid synthesis. The fine‑tuning of flux at the branch point between the 
ED and PP pathways was important for carotenoid biosynthesis. Deletion of pfkAB instead of pgi reduced the carot‑
enoid yield. This suggested that anaplerotic flux of G3P and pyruvate might be necessary for carotenoid biosynthesis. 
Improved carotenoid yields were accompanied by increased biomass and decreased acetate overflow. Therefore, 
efficient use of G3P and pyruvate precursors resulted in a balance among carotenoid biosynthesis, cell growth, and 
by‑product metabolism.
Conclusions: An efficient and balanced MEP‑dependent carotenoid bioconversion strategy involving both the ED 
and PP pathways was implemented by the coordinated modification of diverse central metabolic pathway targets. In 
this strategy, enhancement of the ED pathway for efficient G3P and pyruvate turnover was crucial for carotenoid pro‑
duction. The anaplerotic role of the PP pathway was important to supply precursors for the ED pathway. A balanced 
metabolic flux distribution among precursor supply, NADPH generation, and by‑product pathways was established.
Keywords: Carotenoid biosynthesis, Methyl‑d‑erythritol 4‑phosphate pathway, Genetic targets, Central metabolic 
pathways, Escherichia coli, Balance of precursors
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Background
Bioconversion by engineered microbes in cell facto-
ries is a promising alternative strategy to produce valu-
able chemicals, many of which are expensive to produce 
in their native hosts or by chemical processes [1, 2]. To 
construct an engineered strain with optimal phenotypes, 
the first steps are to enhance native pathways or intro-
duce superior heterogeneous pathways for biosynthesis 
of target chemicals. Another strategy that can be more 
important and laborious is to seek and integrate separate 
genetic modification targets that improve productivity, 
even though the mechanisms of these targets are some-
times poorly understood.
The heterologous production of carotenoids in Escheri-
chia coli is a well-studied example of an engineered 
microbial cell factory in which there has been coordi-
nated modification of multiple targets [3–5]. Carotenoids 
are isoprenoid pigments naturally produced by plants, 
algae, and photosynthetic bacteria. They have attracted 
much attention for industrial use because of their diverse 
physiological effects and their potential applications 
as antioxidants and nutraceuticals [6–8]. Carotenoids 
are structurally derived from two universal isoprene 
units; isopentenyl diphosphate (IPP) and dimethylal-
lyl diphosphate (DMAPP). There are two independent 
pathways for the biosynthesis of IPP and DMAPP: the 
mevalonate pathway from the precursor acetyl-CoA in 
eukaryotic and archaea cells, and the methyl-d-erythritol 
4-phosphate pathway (MEP) pathway from the precur-
sors pyruvate and glyceraldehyde-3-phosphate (G3P) in 
prokaryotic cells and plastids in plants. Bioconversion 
of carotenoids by engineered strain has been developed 
based on either of these two pathways [9, 10].
In E. coli, MEP pathway-dependent carotenoid bio-
synthesis was initially engineered by introducing the 
carotenoid synthesis gene cluster crtEBI and by enhanc-
ing the expressions of genes in the MEP pathway, such 
as dxs and idi [9]. The modification of chromosomal 
targets has been shown to further improve carotenoid 
production [3, 11, 12]. PykFA was the first gene target 
identified to improve carotenoid production. Deletion 
of pykFA reduced the flux from G3P to pyruvate, sug-
gesting that the balance between G3P and pyruvate was 
important for carotenoid synthesis [13]. Additional rate-
limiting targets for carotenoid biosynthesis were further 
explored using either of two major methods: systematic 
approaches using genome-scale modeling; and combi-
natorial approaches based on phenotypic diversification 
and screening. The targets included the global regula-
tors Hnr and ClpXP; the central metabolism enzymes 
YtjC and AceE, which may directly affect precursor lev-
els by catalyzing G3P- and pyruvate-related metabolic 
reactions; and GdhA and FdhF, which might indirectly 
contribute to cofactors or flux balance [5, 11, 12, 14]. 
Thus, as suggested, improving and balancing the precur-
sor supply remains an obstacle for MEP pathway-based 
carotenoid production.
The redistribution of metabolic flux at the pathway 
level is an alternative strategy to improve chemical bio-
synthesis and precursor supply [15]. This strategy is 
always more complex, because desirable flux distribu-
tion is not usually achieved by modifying single genes. 
The MEP pathway begins with the condensation of G3P 
and pyruvate in equal amounts. These precursors are 
primarily supplied by the Embden–Meyerhof–Parnas 
pathway (EMP pathway). The Entner–Doudoroff pathway 
(ED pathway), as a variant glycolysis pathway, produces 
equal amounts of G3P and pyruvate. This superior stoi-
chiometric feature makes the ED pathway a preferable 
route for precursor supply. The strategy to redistribute 
central metabolic pathways has been used to improve 
MEP-dependent carotenoid production by engineered 
microbes [16–18]. However, the exact flux profile is not 
well understood. Systematic modification and analysis of 
gene targets in the EMP, ED, and pentose phosphate (PP) 
pathways may provide new insights on the flux profile.
In addition to the precursor supply, cofactor genera-
tion might be another key factor for the MEP pathway 
and carotenoid biosynthesis. Cofactors such as NAPDH 
and ATP are necessary for MEP reactions. Furthermore, 
the bioconversion efficiency could be affected by the 
accumulation of by-products such as acetate. Thus, it is 
necessary to elucidate flux distribution among precursor 
supply, cofactor generation, and by-product pathways. To 
this end, we implemented an engineering strategy that 
combined systematic genetic target modification and 
central metabolic flux redistribution. Multiple gene tar-
gets were either knocked out or overexpressed to redis-
tribute the fluxes of the EMP, ED, and PP pathways. The 
effects of these modifications on the supply of G3P and 
pyruvate precursors, redox generation, and the metabo-
lism of by-products were analyzed. These results will 
provide guidance for further MEP-pathway engineering 
studies.
Results
Analysis of metabolic engineering targets within EMP, PP, 
and ED pathways
Pyruvate and G3P are the two substrates of 1-deoxy-
d-xylulose 5-phosphate synthase (encoded by dxs), 
the first enzyme in the MEP pathway. The favorable 
stoichiometric ratio of G3P and pyruvate generated 
via the ED pathway inspired the attempt to develop a 
non-EMP pathway route for MEP-dependent carot-
enoid bioconversion. In the EMP pathway, there are 
three steps in the conversion of the starting compound 
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glucose-6-phosphate (G6P) into G3P, the precursor of 
the MEP pathway. Phosphoglucose isomerase (encoded 
by pgi) catalyzes the first glycolytic reaction at the branch 
point of the EMP and ED/PP pathways. The following two 
reaction steps are catalyzed by 6-phosphofructokinase I/
II (encoded by pfkA and pfkB) and fructose bisphosphate 
aldolase II/I (encoded by fbaA and fbaB), respectively. 
Theoretically, blocking either of these genes would direct 
carbon flux from the EMP pathway to the ED/PP path-
way, resulting in enhanced flux through the ED pathway. 
However, deletion of pgi disrupted the recycling of F6P or 
G3P to the oxidative PP pathway, resulting in decreased 
NADPH generation [19]. In the lower part of the EMP 
pathway, the conversion from G3P to pyruvate comprises 
five steps. Among the genes involved in these steps, ytjC 
and pykFA have been identified as targets for modifica-
tion to improve MEP-dependent biosynthesis. The ED 
pathway is a shortcut for G3P and pyruvate generation. 
It produces the two MEP precursors in equal amounts 
via a four-step reaction from G6P. The ED pathway shares 
the first two steps with the PP pathway. The key gene tar-
gets within the ED and PP pathways are shown in Fig. 1. 
Compared with the ED pathway, the PP pathway gener-
ates one additional molecule of NADPH per molecule of 
glucose, which might be necessary for a MEP pathway 
reaction.
Analysis of targets responsible for directing flux from EMP 
pathway to ED/PP pathways
Initially, we constructed two reporter vectors for high 
carotenoid production, pLY036 and pLY10RK; their 
products were neurosporene and lycopene, respectively. 
The crtEBI cassette alone was insufficient for high carot-
enoid production (data not shown). Therefore, an addi-
tional E. coli idi gene was inserted downstream of crtEBI. 
The yields of neurosporene and lycopene from pLY036 
and pLY10RK in wild E. coli BW25113 were 2.05 and 
1.64 mg/g dry cell weight (DCW), respectively.
Various target genes within the EMP pathway were 
deleted to eliminate the flux of G3P and pyruvate through 
the EMP pathway, and the effects on neurosporene pro-
duction were investigated. First, neurosporene produc-
tion over time was compared between the Δpgi strain 
(P036) and the wild-type strain (W036) (Fig.  2a). The 
neurosporene yield of P036 remained stable during cell 
culture and was consistently greater than that of W036. 
The highest yield of P036 (after cell culture for 30 h) was 
approximately 25% greater than that of W036. The W036 
strain produced the highest yield at the beginning of 
bioconversion, and then the yield gradually decreased. 
Considering cell growth and turnover, the decrease in 
neurosporene production per cell mass in W036 might 
be because neurosporene did not further accumulate 
during bioconversion. In contrast, the deletion of pgi 
might have resulted in the continued supply of opti-
mal precursors or cofactors for the MEP pathway. The 
effects of deletions of other EMP genes were then inves-
tigated (Fig.  2b, biomass and  carotenoids  production  of 
all strains in this study are summarized in  Additional 
file 1: Table S1). Compared with the wild-type strain, the 
ΔpfkA and ΔpfkB strains (KA036 and KB036) and the 
ΔpfkAΔpfkB strain (KAB036) produced approximately 
25% more neurosporene, similar to P036. As for the tar-
gets of fructose bisphosphate aldolase, only fbaB was a 
non-lethal deletion. However, deletion of fbaB (strain 
F036) had no effect on neurosporene production.
To further investigate the effects of central flux redistri-
bution on carotenoid biosynthesis, three branching point 
enzymes within the PP and ED pathways, zwf, edd, and 
eda, were each overexpressed in E. coli, and neurosporene 
production was compared among the overexpressing 
strains. As shown in Fig. 3, overexpression of Zwf (strain 
Z036) and Eda (strain E036) increased neurosporene 
Fig. 1 Genetic targets in central metabolic pathways for MEP‑
dependent carotenoid biosynthesis.
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yields by approximately 20 and 12%, respectively, while 
overexpression of edd in strain D036 decreased the yield 
by approximately 20%. The SDS-PAGE results (see Addi-
tional file  2: Figure S1) implied that edd overexpression 
might interfere with the normal expression of other genes 
such as crtI, resulting in decreased neurosporene pro-
duction. These findings indicate that neurosporene bio-
synthesis could be improved by engineering target genes 
that could redistribute flux towards the ED/PP pathways, 
especially the ED pathway.
Efficient substrate use of G3P and pyruvate 
by overexpression of dxs in ED/PP pathways
To further study the effects of redistributed metabolic 
routes on carotenoid production, the pathways were 
modified in a MEP pathway-enhanced background. 
The first enzyme of the MEP pathway, Dxs, was overex-
pressed to increase the flux into the MEP pathway. This 
was achieved using three strategies: replacing the native 
promoter of the chromosomal dxs gene with the strong 
constitutive T5 promoter, which produced 3.20  mg/g 
DCW neurosporene (strain TX036); overexpressing the 
E. coli dxs gene in a low copy-number plasmid (pSC101) 
under the control of the araBAD promoter (pSB1s-dxs), 
resulting in 5.03  mg/g DCW neurosporene production 
in the wild-type strain (SX036); and combining these two 
strategies, resulting in a neurosporene yield of 5.30 mg/g 
DCW (TX-SX036). These three strategies were also 
applied to the Δpgi strain (PTX036 for chromosomal T5 
promoter dxs strain, P-SX036 for the plasmid dxs strain, 
PTX-SX036 for the combined strategy strain) and neu-
rosporene production was compared with that of the 
wild-type strain. After bioconversion, the neurosporene 
yields of PTX036, P-SX036, and PTX-SX036 were 6.94, 
9.40, and 10.71 mg/g DCW respectively, about 1.51–1.88 
times more than that of the wild-type strain (Fig.  4a). 
This result implied that the substrate use of Dxs was sig-
nificantly improved, possibly because of a balanced G3P 
and pyruvate supply from the ED pathway.
To further verify the role of the ED pathway, we 
attempted to improve the precursor supply by coordi-
nated improvements to Eda and Dxs. First, we overex-
pressed Eda and Dxs simultaneously in the Δpgi strain. 
Eda and Dxs were expressed in the pBAD and pSB1s 
plasmids (P-AE036 and P-SX036, and co-transforma-
tion of the two plasmids for P-AE-SX036), respectively. 
As shown in Fig.  4b, the production of neurosporene 
was increased 25% by Eda enhancement, as compared 
with those of P-SX036 and P-AE-SX036. Second, a pro-
tein scaffold was used to spatially recruit Eda and Dxs 
through the interaction between tagged ligands. We 
designed a protein scaffold platform based on two pro-
teins from Clostridium sp.; cellulosome cohesin and 
Fig. 2 Effects of deleting different EMP pathway genes on neuro‑
sporene biosynthesis. a Relative neurosporene production of W036 
(wild type) and P036 (Δpgi) over time; b relative neurosporene 
production of strains with deletions of different EMP pathway genes 
after bioconversion for 12 h.
Fig. 3 Effects of overexpression of different ED/PP pathway genes 
on neurosporene biosynthesis. Relative neurosporene production of 
strains overexpressing different ED/PP pathway genes after biocon‑
version for 12 h.
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dockerin. Eda and Dxs were each fused with different 
dockerins and were co-expressed with scaffold protein 
(SS) containing a cohesin domain in the Δpgi strain. The 
function of SS was confirmed in a His-tag pull down 
assay (Additional file 3: Figure S2). Eda and Dxs co-local-
ized with each other via the interaction between dock-
erins and SS. To balance the expression level with the 
scaffold, Eda and Dxs were co-transcribed under the con-
trol of the araBAD promoter using the low-copy pSB1s 
plasmid in the Δpgi strain (P-A-SEX036), compatible 
with SS expression using the pBAD plasmid. As shown 
in Fig.  4c, neurosporene production was increased by 
approximately 30% in the scaffold platform strain (P-AS-
SEX036). These results confirmed the significant role of 
the ED pathway in carotenoid production.
Fine‑tuning gnd expression to balance PP and ED pathway 
flux
The above results indicated that modification of ED tar-
gets resulted in more efficient precursor use by the MEP 
pathway. However, the ED pathway does not generate 
sufficient NADPH for MEP reactions. To explore the bal-
ance between the ED and PP pathways in this metabolic 
engineering route, either edd or gnd was knocked out in 
the Δpgi strain to construct PP-only and ED-only strains. 
The MEP pathway was enhanced by introducing pSB1s-
dxs. In the bioconversion experiments, neurosporene 
production was significantly decreased in both PP-only 
(PD-SX036) and ED-only (PG-SX036) strains (Fig.  5a), 
indicating that both the PP pathway and the ED pathway 
were important for MEP-dependent biosynthesis. Thus, 
fine-tuning the flux between the ED pathway and the PP 
pathway was necessary to optimize the bioconversion 
process.
Different flux distributions between the PP and ED 
pathways were achieved by coordinated engineering 
of gnd and eda expression. In this experiment, gnd was 
overexpressed at two different levels in either the wild-
type or the Δgnd background: high-level expression was 
obtained using the araBAD promoter; low-level expres-
sion was obtained by introducing rare codons (Gly-Pro) 
at the N-terminal of Gnd peptides under the control of 
the araBAD promoter (Additional file 4: Figure S3). gnd 
was co-expressed with eda. The results indicated that 
moderate gnd expression combined with eda was most 
favorable for neurosporene synthesis in the wild-type 
background (Fig. 5b).
Anaplerotic role of PP pathway is important for carotenoid 
biosynthesis
Next, different targets were modified to determine the 
effects of PP pathway on neurosporene production. 
Compared with Δpgi, ΔpfkAB generated more NADPH 
Fig. 4 Enhanced precursor use by manipulating Dxs and Eda. a Dxs 
was expressed at different strengths, and neurosporene produc‑
tion was compared between Δpgi strain and wild‑type strain after 
bioconversion for 12 h; b neurosporene production in strain simulta‑
neously expressing Dxs and Eda after bioconversion for 12 h; c neu‑
rosporene production in strain in which Dxs and Eda were spatially 
coupled by protein scaffold after bioconversion for 12 h.
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through partial cyclization of the PP pathway [19]. 
ΔpfkA or ΔpfkAB have been reported as useful targets 
to improve NAPDH generation for chemical produc-
tion [20, 21]. If the PP pathway contributes to neuro-
sporene synthesis mainly by generating NAPDH, then 
further improvement of the NADPH supply will benefit 
neurosporene synthesis. To test this assumption, Δpgi 
was replaced by ΔpfkA or ΔpfkAB in an MEP-enhanced 
background. A novel plasmid pSB1s-XID was used to 
further improve the MEP flux, in which E. coli idi and 
ispDF were located downstream of dxs in pSB1s-dxs. 
The neurosporene yields of both KA-SXID036 (ΔpfkA) 
and KAB-SXID036 (ΔpfkAB) were lower than that of 
P-SXID036 (Δpgi) (Fig.  6). We suspected that the PP 
pathway might play additional roles other than sim-
ply generating NADPH for the ED pathway. We further 
deleted the lower EMP pathway targets, pfkA, pfkAB, 
fbaB, and ytjC in the Δpgi background, aiming to block 
the anaplerotic flux from the PP pathway towards G3P 
and pyruvate. Neurosporene production was decreased 
in all these strains (Fig.  6). Together, these results sug-
gested that the PP pathway might play an anaplerotic role 
in supplying precursors for the ED pathway.
Enhanced carotenoid biosynthesis is accompanied 
with improved biomass and decreased acetate overflow
Redistribution of central metabolic flux always has com-
plex effects. To investigate the balance between carot-
enoid biosynthesis and other cell metabolic pathways, 
batch fermentation for neurosporene production was 
conducted in a microbioreactor. As the MEP pathway 
flux still played a significant role in carotenoid produc-
tion, the MEP pathway was further improved by replac-
ing the chromosomal promoter with the T5 promoter to 
drive idi, resulting in PTXI036 and PTXI-SXID036 (con-
taining pSB1s-dxs-idi-ispDF). Both biomass and neu-
rosporene production were monitored in these strains. 
Surprisingly, the synthesis of neurosporene was benefi-
cial for cell growth in the ED/PP pathway strains but not 
in the wild-type strain. As shown in Fig.  7 and Table  1, 
the strains with greater neurosporene synthesis showed 
greater cell growth and biomass, except for SXID036, 
which did not have modified central metabolic pathways. 
Thus, the inclusion of ED/PP pathways led to significant 
improvements in the total carotenoid titer.
Next, we analyzed metabolic intermediates to elucidate 
the coupling mechanism between biomass accumulation 
and carotenoid biosynthesis. The strains were cultured in 
flasks, and acetate accumulation and glucose consump-
tion were monitored. The biomass results were similar 
to those observed in the microbioreactor experiments. 
Improvement of the MEP pathway in the Δpgi back-
ground resulted in significantly reduced acetate accu-
mulation and enhanced glucose consumption (Table  2). 
Thus, we proposed that efficient use of glucose in the 
MEP pathway can establish a flux distribution that is 
favorable not only for carotenoid production but also for 
cell growth. This is probably because of the blockage of 
some by-product pathways, such as acetate overflow.
Combined modification of targets in ED/PP pathways 
for efficient lycopene production
Finally, we developed an optimally engineered strain 
based on the ED/PP pathway route (based on Δpgi, 
Fig. 5 Roles of PP pathway and ED pathway in ED/PP pathway route 
and balance between PP and ED pathways. a Neurosporene produc‑
tion in strains ΔpgiΔedd and ΔpgiΔgnd after bioconversion for 0 or 
12 h; b neurosporene production in strains with different gnd and eda 
engineering genotypes after bioconversion for 12 h.
Page 7 of 12Li et al. Microb Cell Fact  (2015) 14:117 
T5-dxs-idi, pBAD-eda-GCgnd, and pSB1s-dxs-idi-
ispDF) for lycopene production using the reporter vector 
pLY10RK. To improve the total flux for lycopene pro-
duction, glucose supply was optimized by engineering a 
glucose-uptake pathway. Namely, ptsG (encoding glucose 
PTS permease) was knocked out to reduce consump-
tion of pyruvate and ATP. The non-phosphotransferase 
system was improved by inserting the P119-glk cassette 
(glucokinase gene glk under the control of the strong 
constitutive promoter P119) at the chromosomal galR 
locus [releasing the repression of the galactose repres-
sor GalR to increase expression of galactose permease 
(GalP)]. Combining these targets, the resulting strain 
(PTXIGK-AEGG-SXID10RK) produced 17.8  ±  0.2  mg 
lycopene/g DCW in flask culture (Fig.  8). The lycopene 
production was about 3.6 times higher than that of the 
non ED/PP pathway route strain TXI-SXID10RK.
Discussion and conclusions
An ideal microbial cell factory for bioconversion should 
maximize the target metabolic flux with an exact stoichi-
ometric ratio of precursors and cofactors. However, this 
is hard to achieve because of the complexity of metabolic 
flux and its regulation. For MEP-dependent carotenoid 
biosynthesis, imbalanced precursor supply is one of the 
major metabolic bottlenecks, especially considering the 
Fig. 6 Flux balance within EMP pathway and its effects on carote‑
noid biosynthesis. Neurosporene production in strains with deletions 
of different EMP pathway targets after bioconversion for 12 h.
Fig. 7 Batch fermentation to produce neurosporene in a micro‑
bioreactor. Change in relative biomass over time for strains W036 
(BW25113 with pLY036), P036 (Δpgi with pLY036), TX036 (PT5‑dxs with 
pLY036), PTX036 (Δpgi PT5‑dxs with pLY036), PTXI036 (Δpgi PT5‑dxs 
PT5‑idi with pLY036), SXID036 (BW25113 with pSB1s‑dxs‑idi‑ispDF and 
pLY036), PTXI‑SXID036 (Δpgi PT5‑dxs PT5‑idi with pSB1s‑dxs‑idi‑ispDF 
and pLY036).
Table 1 Batch fermentation for  neurosporene production 
in a microbioreactor
Bioconversion was performed in a microbioreactor for 24 h and biomass and 










W036 8.91 1.76 4.7
P036 10.35 1.83 5.68
TX036 16.2 2.40 11.66
PTX036 23.16 4.64 32.24
PTXI036 30.35 5.35 48.71
W‑SXID036 17.3 4.53 23.51
PTXI‑SXID036 40.47 16.69 202.64
Table 2 Acetate accumulation and  glucose consumption 
of strains
Strains were cultured in flasks for bioconversion, and acetate accumulation and 









W036 10 7.86 14.6
P036 10.8 5.80 7.8
W‑SXID036 13.1 2.28 0.03
PSX036 18.3 0.49 0
PTXI‑SXID036 22.6 0.21 0
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limit of precursor (G3P) availability. Disruption of the 
EMP pathway target pykFA has been shown enhance 
lycopene production by retarding the catabolism of G3P 
to pyruvate [13]. In another study, the unexpected accu-
mulation of indole may indicate that the pool of the G3P 
precursor was insufficient, because indole may be a by-
product of an anaplerotic supply of G3P through the 
tryptophan biosynthesis pathway during MEP-dependent 
taxol production [22]. Research on non-EMP pathway 
precursor supply routes has mainly focused on the dele-
tion of pgi [16, 18]. However, a parallel study has shown 
that lycopene yield was improved in a reverse redistribu-
tion pathway route with knocked-out zwf [17]. This indi-
cated that detailed studies of both flux and targets were 
necessary. Herein, we conducted a systematic analysis 
and modification of genetic targets within central meta-
bolic pathways for the redistribution of metabolic flux for 
MEP-dependent carotenoid biosynthesis.
As expected, the ED/PP pathway route created by 
deleting EMP targets and/or improving ED/PP targets 
enhanced carotenoid biosynthesis. Eda and Dxs seemed 
to be key targets for improving carotenoid biosynthesis. 
This was most likely because of their roles in the balance 
and efficient use of G3P and pyruvate precursors sup-
plied by the ED pathway. Further metabolic engineering 
work will focus on coordinated modifications of Eda and 
Dxs. The flux balance between the ED and PP pathways 
was optimized by fine tuning gnd expression. Weak gnd 
expression was better for carotenoid synthesis, indicat-
ing the importance of the proper flux ratio between the 
ED and PP pathways. Although the ED pathway gener-
ated precursors with an exactly balanced ratio for MEP-
dependent biosynthesis, the precursor balance still might 
be perturbed as both G3P and pyruvate could be metabo-
lized in other cellular pathways. The results of this study 
implied that the anaplerotic role of the PP pathway might 
be important for precursor supply. The first clue was that 
the lower part of the MEP pathway was still necessary for 
ED/PP pathway route-dependent carotenoid biosynthe-
sis. In addition, the carotenoid yields of Δpgi strains were 
greater than those of ΔpfkAB strains. The PP pathway 
routes achieved by Δpgi and ΔpfkAB might differ in their 
theoretical flux distribution [21]. Deletion of pgi would 
block the recycling of F6P and G3P into the oxidative PP 
pathway, and increase flux into the lower part of the EMP 
pathway (PP1, Fig. 9). However, pfkAB deletion might cre-
ate a partial cyclization for the recovery of F6P from the 
PP pathway (PP2, Fig. 9). More NADPH was generated by 
the PP2 route than by the PP1 route, while the PP1 route 
supplied more G3P (Fig.  9). A pathway route based on 
Δpgi (ED + PP1) was more favorable for MEP-dependent 
biosynthesis. This suggested that the major role of the PP 
pathway was to sustain the G3P pool, although NADPH 
generated by the PP pathway was also important because 
the ED pathway was redox imbalanced for MEP-pathway 
reactions. However, detailed flux and metabolite analyses 
are required to determine the exact metabolic profile.
The bioconversion efficiency of a given chemical is 
determined by both the stoichiometric yield of the path-
way and the kinetic efficiency of pathway reactions. The 
metabolic route established by deleting pgi not only 
provided a balanced precursor ratio for efficient turno-
ver in the MEP pathway, but also created a well-distrib-
uted metabolic flux between carotenoid biosynthesis 
and other pathways. Acetate overflow is always a major 
metabolic burden in E. coli K-12 strains because of the 
imbalance of central metabolic flux in high-glucose cul-
ture conditions. Surprisingly, the improvement of carot-
enoid biosynthesis in the redistribution route led to both 
greater cell growth and less acetate accumulation. This 
indicated that MEP-dependent carotenoid biosynthesis 
might relieve the metabolic burden by balancing the level 
of redox or metabolites, e.g., pyruvate. Indeed, redistribu-
tion of central metabolic flux always has complex effects. 
A global flux response could occur when MEP precur-
sors are used efficiently or when redox conditions are 
balanced, resulting in flexible adaptation of flux distribu-
tion. Additional factors in central metabolic pathways, 
such as the level of the regulator intermediate fructose 
Fig. 8 Lycopene production in strains with ED/PP pathway route. 
Lycopene production in wild‑type strain (W‑10RK, BW25113 with 
pLY10RK), non‑ED/PP route strain (TXI‑SXID10RK, PT5‑dxs PT5‑idi with 
pSB1s‑dx ‑idi‑ispDF and pLY10RK), ED/PP route strain (PTXI‑SXID10RK, 
Δpgi PT5‑dxs PT5‑idi with pSB1s‑dx ‑idi‑ispDF and pLY10RK), and final 
optimal engineered strain (PTXIGK‑AEGG‑SXID10RK, ΔpgiPT5‑dxsPT5‑
idiΔptsGgalR::P119‑glk with pBAD‑eda‑GCgnd, pSB1s‑dxs‑idi‑ispDF and 
pLY10RK) after bioconversion for 24 h.
Page 9 of 12Li et al. Microb Cell Fact  (2015) 14:117 
6-bisphosphate, might be affected in the redistribution 
route, resulting in various responses and effects on the 
carotenoid biosynthesis pathway. Further research should 
focus on the effects of global regulation of central meta-
bolic networks and their flux in carotenoid biosynthesis.
Methods
Bacterial strains and plasmids
Escherichia coli BW25113 was used as the parental strain 
for genetic modification and carotenoid production. Gene 
knock-out strains were obtained from the KEIO collection 
[23]. Escherichia coli DH5α was used for standard plasmid 
construction. The plasmids used for MEP gene expression 
and as reporter vectors were derived from expression vec-
tors previously developed in our laboratory (unpublished). 
These vectors have the following features: a promoter 
(araBAD), multiple cloning sites, the rrnB terminator, 
origin of replication (p15A, RSF1030 or pSC101), and an 
antibiotic resistance gene (Kan, Cm, or Sm resistance). The 
plasmids pUKM (derivative of pKD4), pKD46, and pCP20 
were used for gene integration. All E. coli strains and plas-
mids used in this study are described in Table 3.
Construction of plasmids and genomic integration
Plasmids were constructed using standard molecular 
biological protocols [24]. For chromosomal promoter 
replacement and gene integration, heterogeneous gene 
fragments were inserted at the MCS site downstream of 
the FRT-kanamycin resistance cassette in pUKM. The 
gene-FRT-kan-FRT fragment was then amplified by PCR. 
Lambda-Red-mediated recombination was performed as 
described elsewhere [25]. For chromosomal phenotype 
integration, P1 virus-mediated transfection was per-
formed as described elsewhere [26]. The primers used in 
this study are listed in Additional file 5: Table S2.
Growth media
LB medium was used for all molecular construction 
experiments and strain cultures. Auto-inducing medium 
[27] was used to induce protein expression. Bioconver-
sion medium was prepared by adding 4% (w/v) glucose to 
M9 medium or LB medium.
Culture conditions
All strains were stored at −80°C until use. Strains were 
pre-cultured in LB medium supplemented with appro-
priate antibiotics at 37°C overnight and then transferred 
into auto-inducing medium to induce expression of 
recombinant proteins. For neurosporene and lycopene 
production, cells were harvested by centrifugation after 
protein induction. Cells were then transferred to bio-
conversion medium at a starting biomass of 4 OD/L. For 
Fig. 9 NADPH and G3P generation through different pathway routes. ED/PP pathways routes were created by either Δpgi or ΔpfkAB, resulting in 
ED + PP1 or ED + PP2. EMP or ED pathway is shown in black; PP pathway is shown in dark gray. NADPH and G3P generation through PP pathways 
in different routes is summarized in corresponding boxes.
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Table 3 Strains and plasmids used in this study
Strain/plasmid Description References
Escherichia coli strains
 BW25113 Wild type K‑12 strain Our lab
 DH5αa For genetic manipulation Invitrogen
 TX PT5‑dxs K‑12 strain, for construction of strains that harboring PT5‑dxs phenotype This study
 TI PT5‑idi K‑12 strain, for construction of strains that harboring PT5‑idi phenotype This study
 GRK galR::P119‑glk K‑12 strain, for construction of strains that harboring galR::P119‑glk phenotype This study
 W036 BW25113, pLY036 plasmid This study
 P036 Δpgi, pLY036 plasmid This study, KEIO
 KA036 ΔpfkA, pLY036 plasmid This study, KEIO
 KB036 ΔpfkB, pLY036 plasmid This study, KEIO
 KAB036 ΔpfkAΔpfkB, pLY036 plasmid This study
 F036 ΔfbaB, pLY036 plasmid This study, KEIO
 W‑AZ036 BW25113, pBAD‑zwf and pLY036 plasmids This study
 W‑AE036 BW25113, pBAD‑eda and pLY036 plasmids This study
 W‑AD036 BW25113, pBAD‑edd and pLY036 plasmids This study
 TX036 PT5‑dxs, pLY036 plasmid This study
 PTX036 ΔpgiPT5‑dxs, pLY036 plasmid This study
 W‑SX036 BW25113, pSB1s‑dxs and pLY036 plasmids This study
 P‑SX036 Δpgi, pSB1s‑dxs and pLY036 plasmids This study, KEIO
 TX‑SX036 PT5‑dxs, pSB1s‑dxs and pLY036 plasmids This study
 PTX‑SX036 Δpgi PT5‑dxs, pSB1s‑dxs and pLY036 plasmids This study
 P‑AE036 Δpgi, pBAD‑eda and pLY036 plasmids This study, KEIO
 P‑A‑SEX036 Δpgi, pBAD, pSB1s‑eda‑dxs and pLY036 plasmids This study, KEIO
 P‑AE‑SX036 Δpgi, pBAD‑eda, pSB1s‑ dxs and pLY036 plasmids This study, KEIO
 P‑AS‑SEX036 Δpgi, pBAD‑SS, pSB1s‑eda‑dxs and pLY036 plasmids This study, KEIO
 PD‑SX036 ΔpgiΔedd, pSB1s‑dxs and pLY036 plasmids This study
 PG‑SX036 ΔpgiΔgnd, pSB1s‑dxs and pLY036 plasmids This study
 P‑AEG036 Δpgi, pBAD‑eda‑gnd and pLY036 plasmids This study, KEIO
 P‑AEGG036 Δpgi, pBAD‑eda‑GCgnd and pLY036 plasmids This study, KEIO
 PG036 ΔpgiΔgnd, pLY036 plasmid This study
 PG‑AE036 ΔpgiΔgnd, pBAD‑eda and pLY036 plasmids This study
 PG‑AEG036 ΔpgiΔgnd, pBAD‑eda‑gnd and pLY036 plasmids This study
 PG‑AEGG036 ΔpgiΔgnd, pBAD‑eda‑GCgnd and pLY036 plasmids This study
 W‑SXID036 BW25113, pSB1s‑dxs‑idi‑ispDF and pLY036 plasmids This study
 P‑SXID036 Δpgi, pSB1s‑dxs‑idi‑ispDF and pLY036 plasmids This study, KEIO
 KA‑SXID036 ΔpfkA, pSB1s‑dxs‑idi‑ispDF and pLY036 plasmids This study
 KAB‑SXID036 ΔpfkAΔpfkB, pSB1s‑dxs‑idi‑ispDF and pLY036 plasmids This study
 PKAB‑SXID036 ΔpgiΔpfkAΔpfkB, pSB1s‑dxs‑idi‑ispDF and pLY036 plasmids This study
 PF‑SXID036 ΔpgiΔfbaB, pSB1s‑dxs‑idi‑ispDF and pLY036 plasmids This study
 PY‑SXID036 ΔpgiΔytjC, pSB1s‑dxs‑idi‑ispDF and pLY036 plasmids This study
 PTXI036 Δpgi PT5‑dxs PT5‑idi, pLY036 plasmids This study
 PTXI‑SXID036 Δpgi PT5‑dxs PT5‑idi, pSB1s‑dx ‑idi‑ispDF and pLY036 plasmids This study
 W10RK BW25113, pLY10RK plasmid This study
 TXI‑SXID10RK PT5‑dxs PT5‑idi, pSB1s‑dx ‑idi‑ispDF and pLY10RK plasmids This study
 PTXI‑SXID10RK Δpgi PT5‑dxs PT5‑idi, pSB1s‑dx ‑idi‑ispDF and pLY10RK plasmids This study, KEIO




 Anabaena sp. PCC7120 crtE, crtB for pLY036 Our lab
 Rhodobacter sphaeroides 2.4.1 crtI for pLY036 Our lab
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bioconversion experiments, cells were cultured in a flask 
at 37°C with shaking at 220 rpm for indicated times, and 
then harvested to quantify products and metabolites.
Measurement of carotenoid production and production 
of other metabolites
Cells were harvested by centrifugation at 12,000g for 
5 min. The cell pellet was washed and then extracted in 
1 mL acetone at 4°C for 1 h. The mixture was centrifuged 
at 12,000g, and the absorbance of the supernatant was 
measured at 470  nm. Neurosporene was quantified as 
described elsewhere [28]. Lycopene was quantified using 
a standard curve of pure standard lycopene (Sigma). 
The biomass was determined by measuring cell density 
(OD600). The acetate concentration was determined by 
HPLC using a C18 column (Agilent), and the glucose con-
centration was measured using a glucose monitor (SDBI).
Batch fermentation in a microbioreactor
For batch fermentation of carotenoids, the strains were 
pre-cultured in auto-inducing medium to induce the 
synthesis of recombinant proteins. Then, cells were trans-
ferred into bioconversion medium in a bioreactor (Bio-
Lector), with a beginning cell density of 4 OD. The cells 
were cultured at 37°C with shaking at 800 rpm.
Additional files
Additional file 1: Table S1. Biomass and carotenoid production of 
strains.
Additional file 2: Figure S1. SDS‑PAGE analysis of recombinant proteins 
produced by Escherichia coli strains: (M) protein markers; (0) strain W036; 
(1) strain W‑AZ036; (2) strain W‑AE036; (3) strain W‑AD036.
Additional file 3: Figure S2. Results of His‑tag pull‑down assay. Briefly, 
strains were induced to express target genes, then cells were lysed by 
sonication. Cell lysates were centrifuged and supernatants were incubated 
with Ni–NTA beads for 6 h. Beads were washed to remove unbound pro‑
teins. Bound proteins were eluted and analyzed by SDS‑PAGE. (M) Markers; 
(1) strain with pSB1s‑eda‑dxs (dockerin‑fused); (2) strain with pBAD‑SS 
(His‑tag fused scaffold protein); (3) strain with pBAD‑SS and pSB1s‑dxs 
(dockerin‑fused); (4) strain with pBAD‑SS and pSB1s‑eda‑dxs.
Additional file 4: Figure S3. SDS‑PAGE analysis of recombinant proteins 
produced by Escherichia coli strains: (M) protein markers; (1) strain P036; (2) 
strain P‑AE036; (3) strain P‑AEG036; (4) strain P‑AEGG036.
Additional file 5: Table S2. Primers used in this study.
Table 3 continued
Strain/plasmid Description References
 Pantoea ananatis crtB. crtI for pLY10RK Our lab
 Pantoea agglomerans crtE for pLY10RK Our lab
Plasmids
 pKD46 For lambda‑Red mediated recombination [25]
 pUKM For lambda‑Red mediated recombination, derived from pKD4 by inserting  
multiple cloning site closed to FRT
Our lab
 pCP20 For lambda‑Red mediated recombination [25]
 pUKM‑T5 For construction of TX and TI, derived from pUKM by inserting T5 promoter  
at multiple cloning site
This study
 pBAD‑HisA ColE1 origin, araBAD promoter, AmpR Invitrogen
 pSB1s pSC101 origin, araBAD promoter, StrR Our lab
 pS95s pSC101 origin, constitutive P119 promoter (derived from iGEM part BBa_J23119), StrR Our lab
 pS95s‑glk pSC101 origin, constitutive P119 promoter, StrR,E. coli glk, for construction of pUKM‑glk This study
 pUKM‑glk For construction of GRK, derived from pUKM by inserting P119‑glk fragment at multiple  
cloning site
This study
 pLY036 p15A origin, araBAD promoter, CmR, Anabaena sp crtEB, R. sphaeroides crtI, E. coli idi This study
 pLY10RK RSF1030 origin, araBAD promoter, KanR, P. agglomerans crtE, P. ananatis crtBI, E. coli idi This study
 pSB1s‑dxs pSC101 origin, araBAD promoter, StrR,E. coli dxs This study
 pSB1s‑eda‑dxs pSC101 origin, araBAD promoter, StrR, dockerin‑fused E. coli eda, dockerin‑fused E. coli dxs This study
 pSB1s‑dxs‑idi‑ispDF pSC101 origin, araBAD promoter, StrR, E. coli dxs,idi,ispDF This study
 pBAD‑zwf ColE1 origin, araBAD promoter, AmpR, E. coli zwf This study
 pBAD‑edd ColE1 origin, araBAD promoter, AmpR, E. coli edd This study
 pBAD‑eda ColE1 origin, araBAD promoter, AmpR, E. coli eda This study
 pBAD‑eda‑gnd ColE1 origin, araBAD promoter, AmpR, E. coli eda,gnd This study
 pBAD‑eda‑GCgnd ColE1 origin, araBAD promoter, AmpR, E. coli eda,GCtag‑gnd This study
 pBAD‑SS ColE1 origin, araBAD promoter, AmpR, clostridium sp cellulose scaffold protein This study
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